Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1216884110 | 12168841 | 10 | F | 2015 | 20160921 | 20160310 | 20160926 | EXP | CA-PFIZER INC-2016145477 | PFIZER | 52.00 | YR | F | Y | 0.00000 | 20160926 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1216884110 | 12168841 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 15 MG, WEEKLY | Y | 11719 | 15 | MG | SOLUTION FOR INJECTION | /wk | |||||
| 1216884110 | 12168841 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 7.5 MG, WEEKLY | 11719 | 7.5 | MG | TABLET | /wk | ||||||
| 1216884110 | 12168841 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 15 MG, WEEKLY | 11719 | 15 | MG | TABLET | /wk | ||||||
| 1216884110 | 12168841 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 200 MG, 2X/DAY | 20235 | 200 | MG | BID | |||||||
| 1216884110 | 12168841 | 5 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | Y | 203214 | 5 | MG | TABLET | BID | |||||
| 1216884110 | 12168841 | 6 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | Y | 203214 | 5 | MG | TABLET | BID | |||||
| 1216884110 | 12168841 | 7 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | Y | 7073 | ||||||||||
| 1216884110 | 12168841 | 8 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | UNK | 0 | |||||||||||
| 1216884110 | 12168841 | 9 | C | MORPHINE | MORPHINE | 1 | UNK | 0 | |||||||||||
| 1216884110 | 12168841 | 10 | C | APO-WARFARIN | WARFARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 1216884110 | 12168841 | 11 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1216884110 | 12168841 | 1 | Rheumatoid arthritis |
| 1216884110 | 12168841 | 2 | Rheumatoid arthritis |
| 1216884110 | 12168841 | 5 | Rheumatoid arthritis |
| 1216884110 | 12168841 | 7 | Rheumatoid arthritis |
| 1216884110 | 12168841 | 8 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1216884110 | 12168841 | OT |
| 1216884110 | 12168841 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1216884110 | 12168841 | Abdominal pain upper | |
| 1216884110 | 12168841 | Alopecia | |
| 1216884110 | 12168841 | Arthralgia | |
| 1216884110 | 12168841 | Condition aggravated | |
| 1216884110 | 12168841 | Cough | |
| 1216884110 | 12168841 | Diarrhoea | |
| 1216884110 | 12168841 | Disease progression | |
| 1216884110 | 12168841 | Drug ineffective | |
| 1216884110 | 12168841 | Fatigue | |
| 1216884110 | 12168841 | Feeling abnormal | |
| 1216884110 | 12168841 | Gastrooesophageal reflux disease | |
| 1216884110 | 12168841 | Increased appetite | |
| 1216884110 | 12168841 | Joint swelling | |
| 1216884110 | 12168841 | Laryngeal neoplasm | |
| 1216884110 | 12168841 | Neck pain | |
| 1216884110 | 12168841 | Oropharyngeal pain | |
| 1216884110 | 12168841 | Pain in extremity | |
| 1216884110 | 12168841 | Pneumothorax | |
| 1216884110 | 12168841 | Pulmonary embolism | |
| 1216884110 | 12168841 | Pulmonary mass | |
| 1216884110 | 12168841 | Rheumatoid arthritis | |
| 1216884110 | 12168841 | Rosacea | |
| 1216884110 | 12168841 | Vomiting | |
| 1216884110 | 12168841 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1216884110 | 12168841 | 3 | 20160710 | 0 | ||
| 1216884110 | 12168841 | 5 | 20160304 | 20160418 | 0 | |
| 1216884110 | 12168841 | 6 | 20160518 | 0 |